More Developmental Disability News
*Autism Linked to Brain Inflammation
my.webmd.com --- WebMD Today Member Services Medical Info Health & Wellness Who We Are Autism Linked to Brain Inflammation Findings Could Lead to New Autism Treatment By WebMD Medical News Reviewed By on Friday November 12 2004 More From WebMD Nov 15 2004 Brain

Associated Press

June 25, 2004

 WASHINGTON -- Newborn mice shriek frantically when mom's away -- unless they have a defect in the same brain pathway that responds to morphine, says research that sheds new light on mother-infant bonding.

To read more click on link above.

Debate grows on vaccine-autism link
Stakes are high as panel reviews risk from mercury


By Scott Allen, Globe Staff, 2/8/2004

The new vaccines kept coming, each containing a tiny amount of mercury as a preservative. For nearly a decade, until regulators realized the problem in 1999, children who received all the recommended vaccinations could have absorbed an elevated amount of the toxin by the time they were 6 months old.

''I feel badly that I didn't pick it up,'' acknowledged an adviser to the National Immunization Program, Dr. Neal Halsey of Johns Hopkins University, at a hearing in Cambridge three years ago.

The preservative, called thimerosal, is used only in trace amounts or not at all in today's US vaccines, but the debate over the human cost of that public health miscalculation is growing. Tomorrow, a panel of the Institute of Medicine will hear new evidence on whether mercury-containing vaccines could explain the apparent increase in autism, a neurological disorder whose victims have difficulty interacting with others or even with talking, and often rely on ritual behavior to cope.

By some estimates, the number of US autism cases has risen tenfold in the past 30 years, although it is unclear how much of the increase reflects greater awareness of the disease rather than a true rise. Many public health officials say the amount of mercury was too small to do much harm, but parents of autistic children say their concerns are not getting a fair hearing because federal health agencies, along with vaccine manufacturers, manipulate studies to play down the role of vaccines in neurological problems.

''I just want to figure out what happened to my kid,'' said Mark Blaxill of Cambridge, whose 8-year-old daughter was diagnosed with autism shortly after she received childhood immunizations.

The anticipated hearing in Washington marks the second time that the institute, an independent science adviser to the government, has tackled the emotional and politically charged issue. In 2001, it concluded that it is ''biologically plausible'' that mercury, used since the 1930s to keep vaccines fresh, causes autism. The institute's Immunization Safety Review Committee found insufficient evidence to substantiate the claim but recommended that mercury be phased out of vaccines for children as a precaution.

Since then, advocacy groups have zeroed in on changes in the vaccine program beginning in the late 1980s as a possible cause of the apparent increase in autism cases. In that period, a broad effort to increase vaccination rates raised the number of children getting thimerosal-containing vaccines, and new vaccines for hepatitis B and a form of bacterial meningitis were added. The US Food and Drug Administration found that an infant would receive more mercury from the shots than the federal safety standard for mercury in the environment, although mercury in vaccines takes a different chemical form.

But studies in the past three years have reached conflicting conclusions about whether any harm was done. The federal Centers for Disease Control and Prevention has found no consistent link, but other specialists, such as Richard Deth of Northeastern University, have found in laboratory experiments that the form of mercury in vaccines can disrupt chemicals that are key to the developing brain.

The stakes in the vaccine review, expected to be made public by May, are enormous, both for the parents of autistic children and for the US childhood immunization program. Already, 3,500 families of autism patients have applied to the National Vaccine Injury Compensation Program, a federal fund that pays hundreds of thousands of dollars for proven vaccine injuries. Hundreds of other families of autism sufferers have sued the government and vaccine makers directly. But ''no one has been compensated one penny yet alleging that mercury in vaccines causes autism,'' said Jack Hamilton, a lawyer in Melbourne, Fla., who represents more than 50 claims before the compensation program.

More broadly, researchers say the thimerosal controversy has contributed to growing anxieties about children's scheduled shots, and they fear a drop in immunization rates even though today's vaccines, collectively, contain 60 times less thimerosal than the 1990s vaccines. A new University of Michigan survey found that 93 percent of pediatricians had encountered at least one parent who refused vaccines for his or her child in the past year.

''We can do tremendously more harm if we in fact create an environment where children don't get vaccines and we begin to have outbreaks of vaccine-preventable illnesses,'' said Dr. Gary Freed, director of the Child Health Evaluation and Research Unit at the University of Michigan and author of the study.

Critics say the CDC itself may have undermined confidence in vaccine safety with a study published last November that found no consistent link between mercury in vaccines and autism. The study, based on a review of records from three health maintenance organizations, found only scattered evidence of an increased risk of tics and speech delays -- but not autism -- for children exposed to thimerosal. The study called for further investigation.

But SafeMinds, an advocacy group, obtained the transcript of a meeting in July 2000 in which study authors and advisers discussed preliminary findings that indicated the risk of autism was 2 1/2 times greater among children who received the highest levels of thimerosal compared with those who received none. ''I do not want [my] grandson to get a thimerosal-containing vaccine until we know better what is going on,'' said Richard Johnston, a pediatrics professor at the University of Colorado, according to the transcript.

The version of the study published in the journal Pediatrics last year found no such link, in part because the researchers obtained new data on children from Harvard Pilgrim health plan that diluted the original findings.

US Representative Dave Weldon of Florida, one of the few doctors serving in Congress, is pressing the CDC to give outside researchers access to the study data and calling for an independent review. ''There may have been a selective use of the data to make the associations in the earliest study disappear,'' he wrote to CDC director Julie Gerberding.

CDC spokesman Von Roebuck declined to respond publicly to Weldon's charge, although the researchers have said they collected the Harvard Pilgrim data to broaden their analysis. And Roebuck defended the CDC's objectivity in the vaccine debate: ''We're really trying to take a look at the science and understand it.''

Scott Allen can be reached at allen@globe.com.

This story ran on page A15 of the Boston Globe on 2/8/2004. © Copyright 2003 Globe Newspaper Company.

http://www.boston.com/dailyglobe2/039/nation/Debate_grows_on_vaccine_autism_li nkP.shtml

Boston Globe Online / Nation | World / Debate grows on vaccine-autism link

News

Radio Show on Autism Radio show about autism broadcasted in the UK. You can listen on the internet

Visit our News Page Developmental Disabilities News

Latest News on Autism

Research Getting Closer to Autism Gene
Forbes - 3 hours ago
FRIDAY, May 13 (HealthDay News) -- Scientists have honed in on a segment of chromosome 17 as the likely home of a gene strongly linked to autism. ...
Mercury and autism: a damaging delusion
Spiked, UK - 1 hour ago
Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: A Medical Controversy, by David Kirby, St Martin's Press, New York, April 2005. ...

Auburn Journal
Family ties guide teen's autism project
Auburn Journal, CA - 9 hours ago
... "I tell them it's because my brother has autism. They usually go, 'What's autism?'". In her research for her senior project, she's ...
Autism's genetic structure offers insights
Washington University Record, Washington - 20 hours ago
A School of Medicine research team has identified regions of DNA that may be related to risk for autism. ... The researchers are learning how autism is inherited. ...
The rising cost of autism 400 percent increase adds to strain on ...
Stratford Star, CT - 20 hours ago
In Stratford, the number of children diagnosed with autism who receive special education services has increased 400 percent since 1996. ...

North County News.com
Finding guidance when coping with autism
Towson Times, MD - May 11, 2005
Having a child with autism is not so much about stark tragedy as about the smaller, everyday kinds of heartaches. Like having a ...
Autism still a mystery, but group offers help North County News.com
all 2 related »
Federal Government Opens Campaign On Autism In Queens
Queens Chronicle, NY - 22 hours ago
... Autism is a neurological disorder that impacts the normal development of the brain in the areas of social interaction and communication skills. ...
Legislature's limit on mercury in infant vaccines is a good bill
News-Leader.com, MO - 12 hours ago
Ultimately, though, their debates are academic. Some studies have shown a connection between mercury and neurological problems such as autism. ...
Senate votes to limit mercury in childhood vaccine News-Leader.com
Mercury-free vaccine bill heads to Blunt St. Joseph News Press
all 4 related »
Autism: Lots of clues, but still no answers
New Scientist (subscription), UK - May 11, 2005
THE risk of autism in twins appears to be related to the month they are born in. The chance of both babies having the disorder is ...
Early test for autism is on the way
New Scientist (subscription), UK - May 11, 2005
WHILE the causes of autism are still unclear, we are closer than ever to a blood test that could detect the disease very early on - perhaps even at birth. ...

RSS Feed Health News

Medical News Archive

Large Study Rejects Vaccine, Autism Link

Experts Say Myth Should Be Put to Rest


Reviewed By Michael Smith, MD

Nov. 6, 2002 -- Autism isn't caused by childhood vaccination, a large study shows. Complete medical data from more than a half million Danish children show no link at all between autism and the measles/mumps/rubella (MMR) vaccine.

Most children get the MMR vaccine at age 12 months. Autism generally becomes apparent by the time a child is 2 years old. It's a scary disorder in which a child loses the ability to connect with others. Widespread use of the MMR vaccine in California began about the same time as researchers noticed an increase in autism cases. Despite rumors of an MMR-autism link, there's no direct evidence that the vaccine causes or contributes to autism. But it's been hard to put this persistent fear to rest.

Subject: 21-year Study To Benefit Kids Looking For Effects On Health

SCHAFER AUTISM REPORT                "Healing Autism:
                             No Finer a Cause on the Planet"
________________________________________________________________
Tuesday, December 8, 2004                       Vol. 8  No. 193


    RESEARCH
   * 21-year Study To Benefit Kids Looking For Effects On Health
     Newspaper editorial
   * Thimerosal Neurotoxicity is Associated with Glutathione
     Depletion: Protection with Glutathione Precursors
   * Mutation Screening And Association Analysis Of Six Candidate
     Genes For Autism On Chromosome 7q
   * Immune Response To Dietary Proteins, Gliadin And Cerebellar
     Peptides In Children With Autism
   * Neuroglial Activation And Neuroinflammation In The Brain Of
     Patients With Autism
   * The mTOR/S6K Signalling Pathway: The Role Of The Tsc1/2 Tumour
     Suppressor Complex And The Proto-Oncogene Rheb
   * Plasma Concentration Of Immunoglobulin Classes And Subclasses
     In Children With Autism In The Republic Of Macedonia:
     Retrospective Study
   * Neurologic Treatment Strategies In Autism: An Overview Of
     Medical Intervention Strategies
   * Brain Asymmetries In Autism And Developmental Language Disorder:
     A Nested Whole-Brain Analysis



RESEARCH

21-year Study To Benefit Kids Looking For Effects On Health
Newspaper editorial

http://www.venturacountystar.com/vcs/opinion/article/0,1375,VCS_125_3382421,
00.html

      A national study slated to being in 2005 could expand the phrase "you
are what you eat" to "you are everything around you." The Children's
National Health Study, sponsored by the U.S. Department of Health and Human
Services and the Environmental Protection Agency, plans to track 100,000
children, including at least 1,200 from Ventura County, from before birth
until age 21. Researchers will be studying the effects of genetics, food,
exposure to chemicals and pesticides, the shape of neighborhoods and
schools, and the social and behavioral structures, on children's growth and
development.
      Ventura County, as one of 96 sites nationwide invited to participate
in the study, is an excellent choice. Researchers hoping to find as broad a
cross section of children as possible will certainly discover a wealth of
lifestyles in this county's urban, suburban and rural communities from which
to compare or contrast data from other parts of the nation.
      In addition to looking at the effect of the whole environment on a
child's health, the study also seeks to understand whether childhood
obesity, asthma, autism and diabetes are nationwide, regional or even local
in scope.
      It could be, as Robert Levin, M.D., Ventura County's Public Health
medical director and health officer, noted in Tuesday's edition of The Star,
that the study might uncover phenomena that affect only the children in the
county.
      Ripe for studying are allergy and asthma problems, which, according to
Sanjiv Verma, a pediatrician with offices in Ventura, Oxnard and Simi
Valley, seem more prevalent here than in colder climes, where pollen
disappears during winter months.
      Researchers believe that the wide-ranging nature of the study -- in 96
locations across 36 states -- and its length, over a 21-year period, will
bring the most comprehensive look at the factors affecting children's
health. Some data collected could be released as early as two or three years
into the study; other data might take the entire 21 years to collect. In
either case, the results can only help health officials and parents
determine the best ways to help children grow up healthy.
      Each location will have a goal of enrolling at least 250 newborns a
year for the first five years of the study. But don't expect the study to be
under way here any time soon. Eight locations, Orange County among them,
have been designated as starting points for the study. Based on the
availability of funding and proposals from those eight locations, at least
three, and possibly all eight, will be asked to begin the study in 2005. The
success of the study in these locations will determine how soon other sites
can implement the study.
      Ventura County can be proud of its selection to participate in the
Children's National Health Study and should eagerly look forward to helping
contribute toward better health for children across the nation.






                 -- > DO SOMETHING ABOUT AUTISM NOW < --

                            SUBSCRIBE. . . !
            . Read, then Forward the Schafer Autism Report.
                   To Subscribe
http://www.SARnet.org/
                  Or mailto:subs@doitnow.com    No Cost!
           _______________________________________________________




* * *


Thimerosal Neurotoxicity is Associated with Glutathione Depletion:
Protection with Glutathione Precursors

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%236641%2320
05%23999739998%23526592%23FLA%23Volume_26,_Issue_1,_Pages_1-148_(January_200
5)&_auth=y&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=1412460&
md5=f8a923f46f2c434e94eccda821d95a36

NeuroToxicology Volume 26, Issue 1 , January 2005, Pages 1-8
doi:10.1016/j.neuro.2004.07.012
Copyright ? 2004 Elsevier Inc. All rights reserved.

S.J. James1, , , William Slikker III2, Stepan Melnyk1, Elizabeth New2, Marta
Pogribna2 and Stefanie Jernigan1
1Department of Pediatrics, University of Arkansas for Medical Sciences and
Arkansas Children's Hospital Research Institute, Little Rock, AR 72202, USA
2Division of Biochemical Toxicology, National Center for Toxicological
Research, Jefferson, AR 72079, USA

Abstract
      Thimerosol is an antiseptic containing 49.5% ethyl mercury that has
been used for years as a preservative in many infant vaccines and in flu
vaccines.
      Environmental methyl mercury has been shown to be highly neurotoxic,
especially to the developing brain.
      Because mercury has a high affinity for thiol (sulfhydryl (SH))
groups, the thiol-containing antioxidant, glutathione (GSH), provides the
major intracellular defense against mercury-induced neurotoxicity.
      Cultured neuroblastoma cells were found to have lower levels of GSH
and increased sensitivity to thimerosol toxicity compared to glioblastoma
cells that have higher basal levels of intracellular GSH.
      Thimerosal-induced cytotoxicity was associated with depletion of
intracellular GSH in both cell lines.
      Pretreatment with 100 M glutathione ethyl ester or N-acetylcysteine
(NAC), but not methionine, resulted in a significant increase in
intracellular GSH in both cell types.
      Further, pretreatment of the cells with glutathione ethyl ester or NAC
prevented cytotoxicity with exposure to 15 ?M Thimerosal.
      Although Thimerosal has been recently removed from most children's
vaccines, it is still present in flu vaccines given to pregnant women, the
elderly, and to children in developing countries.
      The potential protective effect of GSH or NAC against mercury toxicity
warrants further research as possible adjunct therapy to individuals still
receiving Thimerosal-containing vaccinations.
* * *


Mutation Screening And Association Analysis Of Six Candidate Genes For
Autism On Chromosome 7q

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15523497

Bonora E, Lamb JA, Barnby G, Sykes N, Moberly T, Beyer KS, Klauck SM,
Poustka F, Bacchelli E, Blasi F, Maestrini E, Battaglia A, Haracopos D,
Pedersen L, Isager T, Eriksen G, Viskum B, Sorensen EU, Brondum-Nielsen K,
Cotterill R, Engeland HV, Jonge MD, Kemner C, Steggehuis K, Scherpenisse M,
Rutter M, Bolton PF, Parr JR, Poustka A, Bailey AJ, Monaco AP.1 The Wellcome
Trust Centre for Human Genetics, University of Oxford, Oxford, UK.

      Genetic studies have provided evidence for an autism susceptibility
locus (AUTS1) on chromosome 7q.
      Screening for mutations in six genes mapping to 7q, CUTL1, SRPK2,
SYPL, LAMB1, NRCAM and PTPRZ1 in 48 unrelated individuals with autism led to
the identification of several new coding variants in the genes CUTL1, LAMB1
and PTPRZ1.
      Analysis of genetic variants provided evidence for association with
autism for one of the new missense changes identified in LAMB1; this effect
was stronger in a subgroup of affected male sibling pair families, implying
a possible specific sex-related effect for this variant.
      Association was also detected for several polymorphisms in the
promoter and untranslated region of NRCAM, suggesting that alterations in
expression of this gene may be linked to autism susceptibility.European
Journal of Human Genetics advance online publication, 3 November 2004;
doi:10.1038/sj.ejhg.5201315.
      PMID: 15523497 [PubMed - as supplied by publisher]
* * *

Immune Response To Dietary Proteins, Gliadin And Cerebellar Peptides In
Children With Autism

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15526989

Vojdani A, O'Bryan T, Green JA, Mccandless J, Woeller KN, Vojdani E, Nourian
AA, Cooper EL.Section of Neuroimmunology, Immunosciences Lab., Inc., 8693
Wilshire Blvd., Ste. 200, Beverly Hills, California 90211, USA.
drari@msn.com

      The mechanisms behind autoimmune reaction to nervous system antigens
in autism are not understood.
      We assessed the reactivity of sera from 50 autism patients and 50
healthy controls to specific peptides from gliadin and the cerebellum.
      A significant percentage of autism patients showed elevations in
antibodies against gliadin and cerebellar peptides simultaneously.
      For examining cross-reaction between dietary proteins and cerebellar
antigens, antibodies were prepared in rabbits, and binding of rabbit
anti-gliadin, anti-cerebellar peptides, anti-MBP, anti-milk, anti-egg,
anti-soy and anti-corn to either gliadin- or cerebellar-antigen-coated wells
was measured.
      In comparison to anti-gliadin peptide binding to gliadin peptide at
100%, the reaction of anti-cerebellar peptide to gliadin peptide was 22%,
whereas the binding of anti-myelin basic protein (MBP), anti-milk, anti-egg
and anti-soy to gliadin was less than 10%.
      Further examination of rabbit anti-gliadin (EQVPLVQQ) and an!
ti-cerebellar (EDVPLLED) 8 amino acid (AA) peptides with human serum albumin
(HSA) and an unrelated peptide showed no binding, but the reaction of these
antibodies with both the cerebellar and gliadin peptides was greater than
60%.
      This cross-reaction was further confirmed by DOT-immunoblot and
inhibition studies.
      We conclude that a subgroup of patients with autism produce antibodies
against Purkinje cells and gliadin peptides, which may be responsible for
some of the neurological symptoms in autism.
      PMID: 15526989 [PubMed - in process]
* * *

Neuroglial Activation And Neuroinflammation In The Brain Of Patients With
Autism

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15558079

Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER, Delong GR,
Moore JH, McCauley JL, Sutcliffe JS, Ashley-Koch AE, Cuccaro ML, Folstein
SE, Gilbert JR, Pericak-Vance MA.1Department of Medicine, Center for Human
Genetics, IGSP, Duke University Medical Center, Durham, NC, USA.

      Several genome-wide screens have indicated the presence of an autism
susceptibility locus within the distal long arm of chromosome 7 (7q).
      Mapping at 7q22 within this region is the candidate gene reelin
(RELN).
      RELN encodes a signaling protein that plays a pivotal role in the
migration of several neuronal cell types and in the development of neural
connections.
      Given these neurodevelopmental functions, recent reports that RELN
influences genetic risk for autism are of significant interest.
      The total data set consists of 218 Caucasian families collected by our
group, 85 Caucasian families collected by AGRE, and 68 Caucasian families
collected at Tufts University were tested for genetic association of RELN
variants to autism.
      Markers included five single-nucleotide polymorphisms (SNPs) and a
repeat in the 5'-untranslated region (5'-UTR).
      Tests for association in Duke and AGRE families were also performed on
four additional SNPs in the genes PSMC2 and ORC5L, which flank RELN.
      Family-based association analyses (PDT, Geno-PDT, and FBAT) were used
to test for association of single-locus markers and multilocus haplotypes
with autism.
      The most significant association identified from this combined data
set was for the 5'-UTR repeat (PDT P-value=0.002).
      These analyses show the potential of RELN as an important contributor
to genetic risk in autism.
      Molecular Psychiatry advance online publication, 23 November 2004;
doi:10.1038/sj.mp.4001614.
      PMID: 15558079 [PubMed - as supplied by publisher]
* * *

The mTOR/S6K Signalling Pathway: The Role Of The Tsc1/2 Tumour Suppressor
Complex And The Proto-Oncogene Rheb

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15562827

Nobukini T, Thomas G.Friedrich MiescherInstitute, P.O. Box 2543,
Maulbeerstrasse 66, CH-4002, Basel, Switzerland.

      Gene deletion studies in mice and in Drosophila have shown that the
40S ribosomal protein S6 Kinases, dS6K in Drosophila and S6K1 and S6K2 in
mice are important regulators of cell growth in response to insulin
stimulation and nutrition availability.
      Here we chiefly focus on dS6k and S6K1, whose activities are regulated
by an upstream kinase termed the mammalian target of rapamycin (mTOR, or
dTOR in Drosophila).
      Our understanding of the mechanisms regulating the
mTOR/S6K1-signalling pathway will be fundamental in determining the
mechanisms which control cell growth in response to insulin signalling.
      Recent findings from this laboratory and others suggests that the
tumour suppressor complex made of two proteins TSC1/hamartin and
TSC2/tuberin, acts as a negative regulator of mTOR/S6K1 signalling.
      Mutations in either TSC1 or TSC2 are genetically linked to tuberous
sclerosis complex (TSC) syndrome, which can lead to severe pathological
consequences, including mental retardation, ! epilepsy and autism, as well
as cardiac, pulmonary and renal failure.
      Despite a large number of initial reports on the TSC1/TSC2 complex,
and the finding that its activity is regulated by protein kinase B (PKB),
the direct target of the TSC1/TSC2 inhibitory complex was unknown until
recently.
      Since TSC2 has a GTPase-activating domain, or GAP-like sequence,
others and we searched for a small GTP binding protein, which may serve as
the target of TSC1/TSC2 inhibitory complex.
      In our case we took advantage of a genome wide screen in Drosophila
for effectors of cell growth and in parallel searched for a small GTPase
whose activity is up-regulated in TSC2-deficient cells.
      The identified gene was a member of the Ras family of GTPases termed
Ras homologue enriched in brain or Rheb.
      Here we review recent findings demonstrating that the TSC1/TSC2
inhibitory complex normally acts on Rheb to mediate mTOR/S6K1-signalling.
      PMID: 15562827 [PubMed - in process]
* * *

Plasma Concentration Of Immunoglobulin Classes And Subclasses In Children
With Autism In The Republic Of Macedonia: Retrospective Study

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15578810

Trajkovski V, Ajdinski L, Spiroski M.Mirko Spiroski, Institute of
Immunobiology and Human Genetics, Medical Faculty, PO Box 60, 1109 Skopje,
Republic of Macedonia,
mspiroski@yahoo.com.Aim.

      To examine plasma concentration of IgA, IgM, IgG classes, and IgG1,
IgG2, IgG3, and IgG4 subclasses in children with autism.
      Methods.
      Infantile autism was diagnosed by the Diagnostic and Statistical
Manual for Mental Disorders (DSM)-IV and the International Classification of
Diseases (ICD)-10 criteria.
      Plasma samples were collected from 35 autistic subjects, and their 21
siblings (biological brothers and sisters) who served as healthy controls.
      Plasma samples were separated by centrifugation and stored at -20
degrees C until the determination.
      Plasma immunoglobulin classes (IgM, IgA, IgG) and subclasses (IgG1,
IgG2, IgG3, IgG4) were determined using a nephelometer.
      Results.
      Plasma concentrations (mean+/-standard deviation) of IgM and IgG in
autistic children (1.36+/-0.31 g/L and 13.14+/-1.27 g/L, respectively) were
significantly higher (p=0.031 and p=0.023, respectively) in comparison with
their healthy brothers or sisters (1.20+/-0.15 g/L and 12.39+/-0.96 g/L,
respecti! vely).
      Children with autism had significantly higher plasma concentrations of
IgG4 (p<0.001) compared to their siblings (healthy brothers or sisters).
      Plasma concentration of IgA, IgG1, IgG2, and IgG3 were similar in
autistic children and their healthy brothers or sisters.
      Increased plasma concentration of IgG1 was found (p=0.027) in autistic
males (8.06+/-2.40), as compared with their healthy brothers (5.24+/-4.13
g/L).
      Plasma concentrations of IgG (14.28+/-3.66 g/L), and IgG1 (9.41+/-2.20
g/L) in autistic females were increased (p=0.012 and p=0.021, respectively)
in comparison with IgG (11.07+/-2.07) and IgG1 (6.37+/-3.38g/L) in their
healthy sisters.
      Conclusion.
      Children with autism have increased plasma concentration of
immunoglobulines.
      Increased immunoglobulines in children with autism could be a result
of impaired development of the immune system, and/or genetic factors
connected with defense mechanism in these children.
      PMID: 15578810 [PubMed - in process]





                -- > THE SCHAFER AUTISM REPORT IS < --

                0  Canada's most read autism publication
                0  United Kingdom's most read autism publication
                0  The United States' most read autism publication.*

                   A Calendar of Events makes sense.
                     ** NEW UPDATE DECEMBER 1 **
                  
http://www.sarnet.org/events

           _______________________________________________________
           * Whew! That's a pretty tall claim. Here are more details:
             ~200 editions, times 8 pages each, times ~20,000 circulation
             comes to 32 million electronic pages per year.


* * *


Neurologic Treatment Strategies In Autism: An Overview Of Medical
Intervention Strategies

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15575419

Chez MG, Memon S, Hung PC.Department of Neurology, The Chicago Medical
School, North Chicago, IL, USA.

      Child neurologists are likely to be caring for an increasing number of
patients with autistic spectrum disorder (ASD).
      ASD may occur in as many as 1/100 to 1/200 births.
      It appears to be a multifactorial disease, with many phenotypes or
subgroups.
      No simple treatment is currently approved for curing or managing core
symptoms of autism.
      We rationally propose a symptom-based review of what treatments may
offer relief to specific subtypes of clinical behaviors seen in autism.
      There is a lack of clinically based evidence on which to universally
recommend a rational clinical algorithm for treatment; we suggest that
rational pharmacotherapy may offer symptomatic relief to core areas of
dysfunction in the autistic population.
      Future research into rational medical treatment options is desperately
needed.
      PMID: 15575419 [PubMed - in process]
* * *

Brain Asymmetries In Autism And Developmental Language Disorder: A Nested
Whole-Brain Analysis

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Ab
stract&list_uids=15563515

Herbert MR, Ziegler DA, Deutsch CK, O'brien LM, Kennedy DN, Filipek PA,
Bakardjiev AI, Hodgson J, Takeoka M, Makris N, Caviness VS Jr.Center for
Morphometric Analysis, Massachusetts General Hospital, Harvard Medical
School, Boston, USA; Department of Neurology, Massachusetts General
Hospital, Harvard Medical School, Boston, USA; Department of Neurology,
McLean Hospital, Belmont, USA.

      Summary
      We report a whole-brain MRI morphometric survey of asymmetry in
children with high-functioning autism and with developmental language
disorder (DLD).
      Subjects included 46 boys of normal intelligence aged 5.7-11.3 years
(16 autistic, 15 DLD, 15 controls).
      Imaging analysis included grey-white segmentation and cortical
parcellation.
      Asymmetry was assessed at a series of nested levels.
      We found that asymmetries were masked with larger units of analysis
but progressively more apparent with smaller units, and that within the
cerebral cortex the differences were greatest in higher-order association
cortex.
      The larger units of analysis, including the cerebral hemispheres, the
major grey and white matter structures and the cortical lobes, showed no
asymmetries in autism or DLD and few asymmetries in controls.
      However, at the level of cortical parcellation units, autism and DLD
showed more asymmetry than controls.
      They had a greater aggregate volume of significantly asymmetric! al
cortical parcellation units (leftward plus rightward), as well as a
substantially larger aggregate volume of right-asymmetrical cortex in DLD
and autism than in controls; this rightward bias was more pronounced in
autism than in DLD.
      DLD, but not autism, showed a small but significant loss of leftward
asymmetry compared with controls.
      Right : left ratios were reversed, autism and DLD having twice as much
right- as left-asymmetrical cortex, while the reverse was found in the
control sample.
      Asymmetry differences between groups were most significant in the
higher-order association areas.
      Autism and DLD were much more similar to each other in patterns of
asymmetry throughout the cerebral cortex than either was to controls; this
similarity suggests systematic and related alterations rather than random
neural systems alterations.
      We review these findings in relation to previously reported volumetric
features in these two samples of brains, including increased total brain and
! white matter volumes and lack of increase in the size of the corpus ca
llosum.
      Larger brain volume has previously been associated with increased
lateralization.
      The sizeable right-asymmetry increase reported here may be a
consequence of early abnormal brain growth trajectories in these disorders,
while higher-order association areas may be most vulnerable to connectivity
abnormalities associated with white matter increases.
      PMID: 15563515 [PubMed - as supplied by publisher]




          _______________________________________________________

             LOOKING FOR SOMETHING - ANYTHING - ABOUT AUTISM?

             Search The Most Complete Autism News & Info Database
              The Schafer Autism Report -- Updated Fresh Daily
            
http://groups.yahoo.com/group/-AuTeach/messages
         ________________________________________________________





COPYRIGHT NOTICE: The above items are copyright protected. They are for our
readers' personal education or research purposes only and provided at
their request.  Articles may not be further reprinted or used commercially
without consent from the copyright holders. To find the copyright holders,
follow the referenced website link provided at the beginning of each item.
_________________________________________________________________
Lenny Schafer, Editor
mailto:edit@doitnow.com
Edward Decelie  Debbie Hosseini  Richard Miles  Ron Sleith  Kay Stammers

_______________________________________________
SAReport mailing list
SAReport@envirolink.org
You can unsubscribe at:
mailto:unsubscribe@doitnow.com

es shoul

Click Here to visit the Top Ten Nursing Websites!     Vote for me